Intra-Cellular Therapies Inc. (ITCI) stock historical ... Discover historical prices for ITCI stock on Yahoo Finance. View daily, weekly or monthly formats back to when Intra-Cellular Therapies Inc. stock was issued. On The Fly: After Hours Movers TRXC;SLH;IHS;CORE;THO;MRD ... On The Fly: After Hours Movers TRXC SLH IHS CORE THO MRD ITCI SJM Get Free Trial. Forgot password Remember me . Home; News & Analysis down 4.26% after filing to sell 10.25M shares of common stock Intra-Cellular Therapies (ITCI), down 1.73% after filing to sell $300M of common stock The J. M. Smucker Company (SJM), down 1.75% after Securities Registration Statement (simplified Form) (s-3)
Intra-Cellular Therapies Inc. (ITCI) stock historical ... Discover historical prices for ITCI stock on Yahoo Finance. View daily, weekly or monthly formats back to when Intra-Cellular Therapies Inc. stock was issued. On The Fly: After Hours Movers TRXC;SLH;IHS;CORE;THO;MRD ... On The Fly: After Hours Movers TRXC SLH IHS CORE THO MRD ITCI SJM Get Free Trial. Forgot password Remember me . Home; News & Analysis down 4.26% after filing to sell 10.25M shares of common stock Intra-Cellular Therapies (ITCI), down 1.73% after filing to sell $300M of common stock The J. M. Smucker Company (SJM), down 1.75% after
View the real-time ITCI price chart on Robinhood and decide if you want to buy or sell commission-free. get earnings results, and compare Intra-Cellular Therapies against related stocks Down$0.96 (6.10%)As of 5:00 PM PDT after- hours. valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on ITCI. A very good year for the market. Nick Watson Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Intra- Cellular Therapies Inc have a median target of 37.00, with a high estimate of
Securities Registration Statement (simplified Form) (s-3) ITCI Intra Cellular Therapies Inc Securities Registration Statement (simplified Form) (s-3) After Hours Last Trade Last $ 15.82 0.00 (0.00 of our common stock will be substantially higher than the net tangible book value per share of our outstanding common stock. After giving effect to the sale of shares of our common stock in the FDA Cancels Panel Review Of Intra-Cellular Therapies ... But, in the after-hours tare, the stock gained $0.61 or 7.45 percent. The company said it recently provided additional information to the FDA in response to information requests relating to non Intra-Cellular Therapies Inc. - Barron's Sep 27, 2019 · Intra-Cellular Therapies, Inc. is a biopharmaceutical company, which focuses on the discovery and clinical development of innovative, small molecule drugs …
Intra-Cellular Therapies (NASDAQ:ITCI) Stock Quotes and ...